Champions Oncology (CSBR) Tops Q4 EPS by 17c
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q4 EPS of $0.01, $0.17 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $14 million versus the consensus estimate of $12.7 million.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
